1. Home
  2. AVDL vs NWN Comparison

AVDL vs NWN Comparison

Compare AVDL & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • NWN
  • Stock Information
  • Founded
  • AVDL 2015
  • NWN 1859
  • Country
  • AVDL Ireland
  • NWN United States
  • Employees
  • AVDL N/A
  • NWN N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • NWN Oil/Gas Transmission
  • Sector
  • AVDL Health Care
  • NWN Utilities
  • Exchange
  • AVDL Nasdaq
  • NWN Nasdaq
  • Market Cap
  • AVDL 1.4B
  • NWN 1.6B
  • IPO Year
  • AVDL 1996
  • NWN N/A
  • Fundamental
  • Price
  • AVDL $14.54
  • NWN $41.53
  • Analyst Decision
  • AVDL Strong Buy
  • NWN Buy
  • Analyst Count
  • AVDL 7
  • NWN 2
  • Target Price
  • AVDL $19.86
  • NWN $48.00
  • AVG Volume (30 Days)
  • AVDL 1.4M
  • NWN 252.1K
  • Earning Date
  • AVDL 08-07-2025
  • NWN 08-05-2025
  • Dividend Yield
  • AVDL N/A
  • NWN 4.72%
  • EPS Growth
  • AVDL N/A
  • NWN 17.48
  • EPS
  • AVDL N/A
  • NWN 2.58
  • Revenue
  • AVDL $221,075,000.00
  • NWN $1,238,288,000.00
  • Revenue This Year
  • AVDL $63.77
  • NWN $17.95
  • Revenue Next Year
  • AVDL $29.91
  • NWN $5.66
  • P/E Ratio
  • AVDL N/A
  • NWN $16.10
  • Revenue Growth
  • AVDL 132.35
  • NWN 8.40
  • 52 Week Low
  • AVDL $6.38
  • NWN $38.03
  • 52 Week High
  • AVDL $16.66
  • NWN $44.38
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 70.53
  • NWN 55.93
  • Support Level
  • AVDL $14.52
  • NWN $40.84
  • Resistance Level
  • AVDL $14.99
  • NWN $41.60
  • Average True Range (ATR)
  • AVDL 0.53
  • NWN 0.63
  • MACD
  • AVDL -0.00
  • NWN 0.11
  • Stochastic Oscillator
  • AVDL 63.55
  • NWN 71.20

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: